Form 4: Stanley Lau Acquires Stock Options in Cardio Diagnostics Holdings, Inc.
SEC Form 4 Filing
Director Stanley Lau reports acquisition of stock options in Cardio Diagnostics Holdings, Inc. on June 30, 2024.
Summary
- On June 30, 2024, Stanley K. Lau, a director of Cardio Diagnostics Holdings, Inc., acquired 7,575 stock options with an exercise price of $0.55.
- These options are exercisable immediately and expire on June 30, 2034.
- Following this transaction, Lau directly owns 7,575 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, and the sentiment is neutral as it simply reports a transaction.
Industry Context
This filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company directors.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by stakeholders, indicating confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 06/30/2024 | Date of earliest transaction: Stanley Lau acquired stock options. |
| 06/30/2024 | Stock options are exercisable. |
| 06/30/2034 | Expiration date of the stock options. |
| 07/02/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.